Donkey Republic

Donkey Republic

Sälj aktien Köp aktien Handla aktien direkt på nordnet

« Tillbaka

Donkey Republic - Ready to pedal in the high season

29 april 2026

  • Strong profitability in weather-harsh Q1
  • German roll-outs on track; we remain in upper end of guidance
  • FVR raised to DKK 7.5-11.0 (7.0-10.0)

Solid Q1 performance despite weather hit

DONKEY delivered solid +10% revenue growth in Q1'26, driven by +10% fleet growth and a modest +1% improvement in revenue/bike. Despite a harsh weather impact in January and February, albeit normalising in March, the company delivered a strong improvement in profitability, with the EBITDA loss reducing to DKK -1.2m (from DKK -6.3m in Q1'25) on cost-saving initiatives carried out in Q3 and Q4'25.

'26e/'27e/'28e EBITDA raised by 4%/2%/2%

We extrapolate the stronger-than-expected profitability in Q1, raising '26e/'27e/'28e EBITDA by 4%/2%/2%. At the beginning of April, DONKEY started, in line with initial plans, the roll-out to the Ruhr region, and early indicators suggest the Düsseldorf roll-out is also tracking well. This leaves us expecting FY'26 figures in the upper end of guidance, forecasting revenues of DKK 191m (guidance DKK 179m-194m), EBITDA of DKK 42m (guidance 34m-45m) and EBIT of DKK 8m (guidance DKK 1m-9m).

FVR of DKK raised to DKK 7.5-11.0 (7.0-10.0)

Europe's bike-sharing fleet, part of the broader shared micromobility market, is projected to grow at a +15% CAGR until '30e, and we see DONKEY's competitive edge centred around its high-quality fleet (especially after the roll-out of its Gen4 bike), its lower prices (price/cost is 50% of scoring in EU tenders), and stronger relations with the cities it serves, coupled with solid positions in the Tier 2 and Tier 3 segments. Considering market tailwinds and DONKEY's pipeline and commercial momentum, including two recent large-scale wins in Germany, we forecast a revenue CAGR of +20% in '25-'28e (vs. +35% in '18-'25). With improving operating leverage, we model adj. EBITDA increasing from DKK 30m in '25 to DKK 85m in '28e and adj. EBIT reaching DKK 40m. We raise our fair value range to DKK 7.5-11.0/share (7.0-10.0).

Senaste artiklar från alla bolag

Datum Titel Bolag Typ
2026-07-15 Svedbergs Group - Logistics drag persists into H2 Svedbergs G.. Analys
2026-07-15 Infrea - Strong quarter but pegged to Netel Infrea Analys
2026-07-15 Coor - Solid earnings despite softer sales Coor Analys
2026-07-15 Svedbergs Group - Nordics and one-offs weigh Svedbergs G.. Analys
2026-07-14 Nexam Chemical - Solid Q2, profitability within r... Nexam Chemical Analys
2026-07-14 Nexam Chemical - Record sales and first positive ... Nexam Chemical Analys
2026-07-14 Eastnine - Warsaw to become the largest market Eastnine Analys
2026-07-13 Ascelia Pharma - CRL update Ascelia Pharma Analys
2026-07-13 Medicover - Steady as she goes Medicover Analys
2026-07-13 Arctic Paper - Pulp beats paper Arctic Paper Analys
2026-07-13 Studsvik - Gearing up for the new-build era Studsvik Analys
2026-07-10 StrongPoint - The American dream StrongPoint Analys
2026-07-10 Careium - The pressure valve starting to open Careium Analys
2026-07-10 StrongPoint - Solid Q2 performance StrongPoint Analys
2026-07-10 Careium - Growth's comeback tour continues Careium Analys
2026-07-09 Infrea - Road tripping with Netel Infrea Analys
2026-07-08 Alligo - Softer growth, but margin recovery conti... Alligo Analys
2026-07-08 Qliro - Key earnings drivers intact Qliro Analys
2026-07-07 Nexam Chemical - We expect a firmer sequential qu... Nexam Chemical Analys
2026-07-07 Eastnine - Adding in Warsaw Eastnine Analys